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Functional imaging plays an important part in the
diagnosis and risk stratification of patients with known
or suspected coronary artery disease (CAD). Results
from an ASNC member survey performed in 2011
showed that pharmacological stress was used in well
over half (59%) of all radionuclide myocardial perfusion
imaging (MPI) studies.1 Adenosine and regadenoson are
commonly used pharmacological stress agents in both
MPI studies and cardiovascular magnetic resonance
(CMR) for the assessment of ischemia in CAD patients.
As recommended by guidelines, the agents are either
administered using a weight-based dosage over several
minutes in the case of adenosine or a fixed dosage bolus
independent of weight for regadenoson.2 The assump-
tion is that if caffeine and antagonistic medications are
withdrawn, the stress test is considered valid if admin-
istered as per guidelines. Unlike in exercise treadmill
testing and dobutamine stress, there is no target heart
rate endpoint to confirm the adequacy of stress with
vasodilator stress. Although symptoms (chest pain and
dyspnea) and ECG changes are non-specific in the
context of vasodilator stress, most imaging centers will
appropriately document patient-reported symptoms and
hemodynamic response to help inform stress adequacy.
An adequate vasodilator response with adenosine
infusion has been defined as an increase in heart rate of
more than 10 beats per minute or a decrease in systolic
blood pressure of at least 10 mmHg.3 Using these
thresholds, up to a third of false-negative stress CMR
results in the CE-MARC study were attributed to inad-
equate pharmacological vasodilator stress.4 The notion,
however, that these hemodynamic cut-offs provide a
reliable assessment of stress adequacy is misguided.
Chronotropic incompetence is common in patients with
cardiovascular disease (particularly that which involves
the right coronary artery) and is itself an independent
predictor of major adverse cardiovascular events and
overall mortality.5 Patients with end-stage liver disease
undergoing pre-transplant risk stratification may also be
less suitable for pharmacological vasodilator stress
because of high resting myocardial blood flows,6 a
factor which likely contributes to the lower specificity
and sensitivity of myocardial perfusion imaging in this
disease cohort.7 Moreover, although recommended by
guidelines, a number of commonly used cardiovascular
medications (including beta-blockers, digitalis, calcium
antagonists and amiodarone) are not uniformly with-
drawn and could confound the heart rate response to
stress. It is conceivable that these limitations in assess-
ing stress adequacy contribute to the 10% rate of false-
negative PET MPI results, even when performed in
expert centers.8 Collectively, these observations make it
imperative for imaging physicians to use everything in
their technological armamentarium to facilitate an
objective assessment of stress adequacy and include this
information in their reports as has been suggested in
consensus guidelines.9
One potential solution to this issue is to exploit the
concept of splenic switch off. Splenic contraction is not
a new phenomenon—it was originally described in 1963
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in animal physiology experiments involving exercise
and pharmacological stress.10 Over 30 years ago, it was
reported in radionuclide ventriculography among
patients undertaking maximal symptom-limited supine
bicycle ergometer exercise.11 It was not until 2015,
however, that the CMR imaging community embraced
its potential for gauging the adequacy of adenosine
vasodilator stress in real-world clinical practice.12
Splenic perfusion in vivo is intrinsically regulated by
adenosine via the A1 and A2B receptors; endogenous
adenosine results in a reduction in splanchnic blood flow
via an A1-mediated mechanism and mediates coronary
vasodilation by acting predominantly on the A2A
receptor.13 It is worth emphasizing that SSO is not
observed in patients undergoing regadenoson stress due
to its specificity as a A2A receptor agonist; SSO is,
therefore, only applicable to adenosine and
dipyridamole.
The study presented by Bakula and colleagues in
the current edition of JNC is a welcome addition to the
literature.14 The authors should be commended for their
efforts to compare the role of adenosine-induced splenic
switch off (SSO) as a marker of adenosine stress ade-
quacy in nitrogen-13 ammonia PET versus CMR. The
use of simultaneous hybrid PET/CMR multi-modality
imaging and the inclusion of both quantitative parame-
ters of splenic activity alongside visual assessment for
SSO are important advantages of the study. The
demonstration of the feasibility of adopting SSO in PET
MPI as well as CMR practice is the study’s major
finding. Using CMR as the reference standard, the
authors used a ROC analysis to demonstrate that a
splenic activity ratio (SAR) of 0.46 was the most
accurate cut-off for prediction of SSO.
All of the current PET scanners with CT component
will allow inclusion of the spleen within the imaging
field of view. Indeed, in an observational cohort study of
839 patients in which 703 (84%) of the dipyridamole
Rb-82 PET MPI scans included visualization of the
spleen, splenic response ratio (equivalent to SAR) was
independently associated with major adverse cardio-
vascular events in subjects without ischemia (defined by
a normal summed difference score on relative perfusion
imaging).15 Thus, as well as identifying patients with
inadequate pharmacologic stress and minimizing false-
negative results, splenic response may offer prognostic
utility.
The study of Bakula et al. 14 is, however, subject to
some limitations. The decision to include myocarditis
patients in this cohort is debateable. Myocarditis is a
heterogeneous condition with a wide spectrum of clini-
cal presentations, causes and pathologies; equally, only
14 patients (28%) included in the study had a history of
coronary artery disease at baseline. Using visual
assessment of SSO by CMR as the reference standard
technique was both practical and logical; however, the
inclusion of more patients with coronary imaging (only
2 in this study) would have proven insightful. Finally,
despite the recognized drawbacks of using changes in
hemodynamic parameters to gauge stress adequacy,
because this information is still used in routine clinical
practice to help determine stress adequacy, the inclusion
of such indices (including rate pressure product) and
how these related to the presence/absence of SSO would
have improved the study.
In the era of quantitative MPI which is feasible with
PET CT (and not yet with dynamic SPECT), SSO may
be useful in patients undergoing adenosine/dipyridamole
stress to differentiate between inadequacy of stress (SSO
absent, very low myocardial perfusion reserve (MPR)
and normal relative perfusion) and balanced ischemia/
microvascular dysfunction (SSO present, low or very
low MPR and normal relative perfusion; see Figure). As
microvascular dysfunction is a diagnosis of exclusion,
this would require invasive angiogram or CT coronary
angiogram (feasible with hybrid PET/CT systems in a
single setting) to confirm absence of obstructive epi-
cardial disease.
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. In summary, this study highlights an important
future role for SSO as an imaging tool in the assessment
of stress adequacy during adenosine (and dipyridamole)
perfusion PET/CT imaging and suggests that this simple
observation should not be limited exclusively to CMR
imaging units.
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Figure. Proposed algorithm for the inclusion of splenic switch off in a hybrid imaging approach to
distinguish between inadequate stress and reduced global myocardial perfusion reserve secondary
to balanced ischemia from 3-vessel coronary disease and microvascular dysfunction. MPR
Myocardial perfusion reserve; 3VD 3-vessel coronary artery disease. *Microvascular dysfunction is
a diagnosis of exclusion, which would require invasive angiogram or CT coronary angiogram
(feasible with hybrid PET/CT systems in a single setting).
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